InsidersTradesSigma
Track the Elicera Therapeutics AB share price and the full management transaction log of the company, a listed issuer based in Finland. Shares trade on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Elicera Therapeutics AB has recorded 0 public disclosures. Market capitalisation: €158.2m. Every trade is openly available.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Elicera Therapeutics AB is a Swedish biopharmaceutical company focused on developing gene and cell therapies for cancer treatment. It is listed on the XSTO exchange.